MACITENTAN for Chronic obstructive pulmonary disease: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 24 adverse event reports in the FDA FAERS database where MACITENTAN was used for Chronic obstructive pulmonary disease.
Most Reported Side Effects for MACITENTAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 8,315 | 18.4% | 1,685 | 5,903 |
| Death | 5,864 | 12.9% | 5,789 | 2,120 |
| Headache | 4,856 | 10.7% | 575 | 2,694 |
| Diarrhoea | 3,669 | 8.1% | 574 | 2,268 |
| Pneumonia | 3,531 | 7.8% | 810 | 3,162 |
| Nausea | 3,463 | 7.6% | 456 | 2,116 |
| Hospitalisation | 3,414 | 7.5% | 500 | 3,372 |
| Fatigue | 3,172 | 7.0% | 485 | 1,899 |
| Fluid retention | 2,861 | 6.3% | 575 | 2,150 |
| Dizziness | 2,704 | 6.0% | 337 | 1,673 |
| Malaise | 2,521 | 5.6% | 431 | 1,590 |
| Pulmonary arterial hypertension | 2,390 | 5.3% | 1,204 | 1,695 |
| Hypotension | 2,318 | 5.1% | 519 | 1,691 |
| Cough | 2,294 | 5.1% | 314 | 1,404 |
| Condition aggravated | 2,198 | 4.9% | 638 | 1,538 |
Other Indications for MACITENTAN
Pulmonary arterial hypertension (29,246)
Product used for unknown indication (9,498)
Pulmonary hypertension (5,228)
Cor pulmonale chronic (254)
Portopulmonary hypertension (153)
Connective tissue disorder (107)
Systemic scleroderma (74)
Pulmonary embolism (68)
Heart disease congenital (56)
Heritable pulmonary arterial hypertension (43)
Other Drugs Used for Chronic obstructive pulmonary disease
TIOTROPIUM (20,175)
FLUTICASONE\SALMETEROL (8,896)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (8,730)
ALBUTEROL (8,572)
BUDESONIDE\FORMOTEROL (6,539)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (4,580)
UMECLIDINIUM\VILANTEROL TRIFENATATE (4,512)
DUPILUMAB (3,526)
ALBUTEROL\IPRATROPIUM (3,289)
ACLIDINIUM (2,321)